CDKN1A and cholangiocarcinoma: In addition, the genotoxic drug, bromodeoxyuridine, displayed a stronger induction of senescence, suggesting that CCA cells’ senescent state is mainly controlled by DNA damage response pathways relating to p53/p21 signaling.